customer service software
0

Embolization Particles (General Surgery) - Global Market Analysis and Forecast Model

  • Published Date: 31 Dec 2018
  • Category: Healthcare and Medical
  • Country: Global
Embolization Particles (General Surgery) - Global Market Analysis and Forecast Model

Summary

Embolization Particles (General Surgery) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within General Surgery therapeutic area.

Embolization is a procedure that uses particles such as tiny gelatin sponges or beads to block a blood vessel. The Embolization particles are used to stop bleeding or are used to block the flow of blood to a tumor. These particles are generally used to treat some types of liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and Benign Prostatic Hyperplasia. Despite similar appearances and handling characteristics, each one of the embolic agents has specific physical and chemical properties that affect their in vivo behavior.

Clinicians have to familiarize themselves with these differences to make the correct choice of embolic agent, and then to use the correct protocol for embolization. The sizes of Embolization particles can vary from range of 30-1200 m depending upon disease indications. The Embolization Particles market is driven by a wide variety of factors; however the market is primarily driven by the increase in the aging population, the increase in patients with liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and Benign Prostatic Hyperplasia. The primary driver of the market is the increasing prevalence of cancer, hemorrhages and malignant hypertension caused due to renal failure.

Each of the covered 39 countrys color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model

Currently marketed Embolization Particles and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Embolization Particles market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Embolization Particles market.
- Competitive dynamics insights and trends provided for Embolization Particles market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Merit Medical Systems Inc, BTG Plc, Cook Group Inc, Sirtex Medical Ltd, Interface Biomaterials B.V. , Terumo Corp

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you wont find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of this Embolization Particles marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving this Embolization Particles market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact this Embolization Particles market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific this Embolization Particles market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Publisher Name : GlobalData

Thyroid Function Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Thyroid Function Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative

View Report

Colorectal Cancer Screening Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Colorectal Cancer Screening Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to

View Report

Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports